Get Full Government Meeting Transcripts, Videos, & Alerts Forever!
Get email alerts on the Benefits Glp1 topic
No spam. Unsubscribe anytime.
SSD trustees face staff backlash after vote to end GLP‑1 coverage
Summary
Special School District trustees voted in June to stop covering GLP‑1 medications for weight‑loss indications; staff and community members urged the board to reconsider, citing health benefits and contested district cost estimates.
The Special School District of St. Louis County board of education voted 5–2 on June 24 to end coverage of GLP‑1 medications for weight‑loss indications, a decision staff and community members said will harm employees who rely on the drugs for medically recommended care.
The board’s public statement at the August meeting recalled that coverage began April 1, 2023, after the district’s insurance broker estimated annual cost at $110,000; the district reported that first‑year costs were about $1.9 million and later received broker advice to discontinue coverage for the weight‑loss indication. The statement said trustees had earlier tabled the matter to gather information and hear from staff and experts before the June vote to stop coverage effective January 2025.
Three written public comments read to the board urged reconsideration. Aaron Klyman, a teacher with SSD, said removing the benefit felt like a personal loss after he described living with PCOS and following medical guidance: “This medication was the key for my body,” he said. Jennifer Hyatt, who said she benefited from GLP‑1 treatment, told the board that losing coverage could worsen long‑term health and raise downstream medical costs. Paul Kaufman, speaking as a union representative, questioned the district’s cost accounting: he cited a district newsletter number that continued coverage would cost $4.1 million while a July presentation to the board reported the district tracking millions under budget on benefits and salaries.
Board materials and public remarks emphasized competing priorities: trustees said they recognize health benefits for individual users but must weigh overall plan affordability for the district. Commenters proposed alternatives such as higher copays or opt‑in coverage tiers so employees could retain access while limiting district exposure.
The board did not reverse the June 24 decision during the August meeting. District staff said they would continue communication with employees ahead of open enrollment and that benefits transitions and alternatives would be detailed during upcoming enrollment materials.
What’s next: trustees previously set the change to take effect in January; district staff will provide open‑enrollment information and additional communications to help affected employees evaluate alternatives.
